Global Pharmaceuticals & Biotech Big Green Snowflakes

Ferozsons Laboratories

Market Cap: PK₨17.9b

Engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally.

Elite Pharmaceuticals

Market Cap: US$739.4m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Xenon Pharmaceuticals

Market Cap: US$2.9b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Aclaris Therapeutics

Market Cap: US$230.7m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Adial Pharmaceuticals

Market Cap: US$7.6m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

Metagenomi

Market Cap: US$69.8m

A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.

Lexaria Bioscience

Market Cap: US$19.6m

Operates as a biotechnology company.

I-Mab

Market Cap: US$529.0m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

Stoke Therapeutics

Market Cap: US$1.2b

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

IO Biotech

Market Cap: US$118.6m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

Theracryf

Market Cap: UK£5.3m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

Zura Bio

Market Cap: US$143.0m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

IDL Diagnostics

Market Cap: SEK 94.4m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Selvita

Market Cap: zł585.5m

Operates as a contract research organization worldwide.

Coherus Oncology

Market Cap: US$156.9m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Azenta

Market Cap: US$1.3b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Inotiv

Market Cap: US$55.3m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Replimune Group

Market Cap: US$454.3m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

Elutia

Market Cap: US$62.5m

A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.

MDxHealth

Market Cap: US$175.2m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Coya Therapeutics

Market Cap: US$104.9m

A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).

BSF Enterprise

Market Cap: UK£2.8m

Develops and commercializes cutting-edge tissue-engineered solutions.

Opus Genetics

Market Cap: US$85.7m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).

Taysha Gene Therapies

Market Cap: US$894.8m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

China Pharma Holdings

Market Cap: US$5.9m

Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.

Ironwood Pharmaceuticals

Market Cap: US$180.3m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

Belite Bio

Market Cap: US$2.2b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

MedinCell

Market Cap: €617.8m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Laboratorio Reig Jofre

Market Cap: €236.8m

A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics.

NRx Pharmaceuticals

Market Cap: US$74.9m

A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.

Disc Medicine

Market Cap: US$2.1b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Incannex Healthcare

Market Cap: US$51.1m

A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.

Chordia Therapeutics

Market Cap: JP¥10.1b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

GlycoNex Incorporation

Market Cap: NT$2.9b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

J2KBIO

Market Cap: ₩56.1b

A bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation.

Yifan Pharmaceutical

Market Cap: CN¥18.1b

Engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally.